Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HER2-positive Carcinoma of Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06123988
What this trial is testing

Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women With Hormone Receptor Positive Advanced Breast Cancer

Who this might be right for
HER2-positive Breast CancerAdvanced Breast Cancer
University of Miami 260
Testing effectiveness (Phase 2)Looking for participantsNCT07383818
What this trial is testing

Neoadjuvant Therapy Combined With Trastuzumab Rezetecan and Toripalimab for HR+/HER2-low Breast Cancer (NEOTORCH-BREAST 08)

Who this might be right for
HR Positive/HER2 Low Breast Cancer
First Affiliated Hospital of Zhejiang University 111
Not applicableStudy completedNCT04249440
What this trial is testing

Preoperative Systemic Therapy vs Upfront Surgery in HER2 Positive Early Breast Cancer

Who this might be right for
Breast CancerHER2Preoperative Systemic Treatment
Zhejiang Cancer Hospital 1,067
Early research (Phase 1)Study completedNCT05551897
What this trial is testing

Assess the Pharmacokinetics of Camizestrant (AZD9833) When Administered Alone and in Combination With Itraconazole

Who this might be right for
Healthy Subjects
AstraZeneca 14
Not applicableLooking for participantsNCT06518382
What this trial is testing

Tumor-microenvironment Spatial Interaction to Identify Markers of Resistance to Therapy in HER2+ Breast Cancer Patients

Who this might be right for
HER2-positive Breast Cancer
Giampaolo Bianchini 10
Testing effectiveness (Phase 2)UnknownNCT00687648
What this trial is testing

Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Centre, Singapore 70
Large-scale testing (Phase 3)Temporarily pausedNCT05503108
What this trial is testing

Fasting Mimicking Diet Program to ImpRovE ChemoTherapy in Hormone Receptor Postive (HR+), HER2- Breast Cancer

Who this might be right for
Fasting Mimicking DietHER2-negative Breast CancerHormone Receptor-positive Breast Cancer+3 more
Leiden University Medical Center 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07782840
What this trial is testing

QL1706 Plus Neoadjuvant Endocrine Therapy in HR-Positive/HER2-Negative Breast Cancer With a Poor Response to Neoadjuvant Chemotherapy

Who this might be right for
Breast Cancer
Hebei Medical University Fourth Hospital 40
Testing effectiveness (Phase 2)UnknownNCT06125834
What this trial is testing

Trastuzumab Emtansine (T-DM1) in HER2-positive Breast Cancer Patients With Progressive Disease After TKIs or HP Therapy

Who this might be right for
Advanced Breast CancerObjective Response RateTrastuzumab Emtansine
The First Affiliated Hospital with Nanjing Medical University 36
Testing effectiveness (Phase 2)Looking for participantsNCT07506876
What this trial is testing

Concurrent Neoadjuvant Chemo/Endocrine Therapy in HER2+ Breast Cancer

Who this might be right for
Breast Cancer - Infiltrating Ductal CarcinomaHER-2 Positive Breast Cancer
Legacy Health System 30
Not applicableLooking for participantsNCT06867484
What this trial is testing

Breast Re-irradiation After Second Ipsilateral Lumpectomy

Who this might be right for
Breast CancerCancerCancer of the Breast+3 more
Youssef Zeidan 114
Testing effectiveness (Phase 2)Ended earlyNCT01658358
What this trial is testing

ErbB2 Positive Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
China Medical University Hospital 15
Testing effectiveness (Phase 2)Looking for participantsNCT04899908
What this trial is testing

Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases

Who this might be right for
Brain CancerBrain MetastasesMelanoma+13 more
Brigham and Women's Hospital 134
Not applicableStudy completedNCT02752893
What this trial is testing

Estrogen Receptor-Positive Breast Cancer Patient-Derived Xenografts

Who this might be right for
Breast Cancer
Dartmouth-Hitchcock Medical Center 10
Testing effectiveness (Phase 2)UnknownNCT04095390
What this trial is testing

A Phase Ⅱ Trial of Pyrotinib Combination With CDK4/6 Inhibitor SHR6390 in Patients Prior Trastuzumab-treated Advanced HER2-Positive Breast Cancer

Who this might be right for
Metastatic Breast CancerHER2-positive Breast Cancer
Jinming Yu 60
Not applicableUnknownNCT04609540
What this trial is testing

Pyrotinib Combined With Trastuzumab And Chemotherapy in HER2-positive MBC

Who this might be right for
HER2-positive Breast CancerMetastatic Breast Cancer
Shandong Cancer Hospital and Institute 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07177950
What this trial is testing

A Two-cohort Study of SHR-A1811 in the Treatment of HER2-positive Breast Cancer With Brain Metastases

Who this might be right for
Breast CancerBrain MetastasesLeptomeningeal Metastasis
Peking University Cancer Hospital & Institute 51
Large-scale testing (Phase 3)Study completedNCT02149524
What this trial is testing

Compare the Effect of SB3 and Herceptin® in Women With HER2 Positive Breast Cancer

Who this might be right for
HER2 Positive Early or Locally Advanced Breast Cancer
Samsung Bioepis Co., Ltd. 875
Testing effectiveness (Phase 2)Looking for participantsNCT07007559
What this trial is testing

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

Who this might be right for
Breast Cancer, Metastatic
ALX Oncology Inc. 120
Testing effectiveness (Phase 2)Study completedNCT02048059
What this trial is testing

ANG1005 in Breast Cancer Patients With Recurrent Brain Metastases

Who this might be right for
Breast CancerBrain Metastases
Angiochem Inc 72
Next Page